Antibiotic Exposure and Risk for Death or Bronchopulmonary Dysplasia in Very Low Birth Weight Infants

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Jornal de Pediatria

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpeds.2016.11.002PMID 27908652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants.

  2016cited by this paper
• The Airway Microbiome at Birth

  2016cited by this paper
• Optimizing the Use of Antibacterial Agents in the Neonatal Period

  2016cited by this paper
• Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study.

  2016cited by this paper
• A Necrotizing Enterocolitis-Associated Gut Microbiota Is Present in the Meconium: Results of a Prospective Study.

  2016cited by this paper
• Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery

  2015cited by this paper
• Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

  2015cited by this paper
• Longitudinal Analysis of the Premature Infant Intestinal Microbiome Prior to Necrotizing Enterocolitis: A Case-Control Study

  2015cited by this paper
• When do confounding by indication and inadequate risk adjustment bias critical care studies? A simulation study

  2015cited by this paper
• The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants.

  2015cited by this paper
• Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease.

  2015cited by this paper
• Reduced airway microbiota diversity is associated with elevated allergic respiratory inflammation.

  2015cited by this paper
• Clinical Risk Index for Babies (CRIB II) Scoring System in Prediction of Mortality in Premature Babies.

  2015cited by this paper
• Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants.

  2015cited by this paper
• The airway microbiome in patients with severe asthma: Associations with disease features and severity.

  2015cited by this paper
• A Revised Birth Weight Reference for the United States

  2014cited by this paper
• The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia

  2014cited by this paper
• Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges.

  2014cited by this paper
• Prolonged Early Antibiotic Use and Bronchopulmonary Dysplasia in Very Low Birth Weight Infants

  2014cited by this paper
• Fecal Microbiota in Premature Infants Prior to Necrotizing Enterocolitis

  2011cited by this paper
• Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants.

  2011cited by this paper
• Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis

  2011cited by this paper
• Prolonged Duration of Initial Empirical Antibiotic Treatment Is Associated With Increased Rates of Necrotizing Enterocolitis and Death for Extremely Low Birth Weight Infants

  2009cited by this paper
• Reduction of Bronchopulmonary Dysplasia After Participation in the Breathsavers Group of the Vermont Oxford Network Neonatal Intensive Care Quality Improvement Collaborative

  2006cited by this paper
• Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia

  2005cited by this paper
• Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis in Very Low Birth Weight Infants

  2005cited by this paper
• Practice Variation in Suspected Neonatal Sepsis: A Costly Problem in Neonatal Intensive Care

  2005cited by this paper
• Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia.

  2004cited by this paper
• Duration of Empiric Antibiotics for Suspected Early-Onset Sepsis in Extremely Low Birth Weight Infants

  2003cited by this paper
• Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.

  2002cited by this paper
• An antibiotic policy to prevent emergence of resistant bacilli.

  2000cited by this paper

• Stratified Comparison of Risk Factors for Mild Versus Moderate-to-Severe Bronchopulmonary Dysplasia in Very Preterm Infants (< 32 Weeks Gestational Age)

  2026cites this paper
• NEC-Associated Bronchopulmonary Dysplasia and the Gut–Lung Axis in Preterm Infants

  2025cites this paper
• The impact of hyperoxia and antibiotics on lung mesenchymal cells in experimental bronchopulmonary dysplasia.

  2025cites this paper
• Intestinal microbiota changes in early life of very preterm infants with bronchopulmonary dysplasia: a nested case–control study

  2025cites this paper
• Preterm prelabour rupture of membranes: the use of amniocentesis to detect intra-amniotic infection reduces maternal and neonatal duration of antibiotic exposure.

  2025cites this paper
• Is Shorter (3–4 Days) Antibiotic Therapy Adequate Compared to Standard (5–7 Days) Duration in Neonates with Suspected (Culture Negative) Sepsis? Yes

  2025cites this paper
• Risk factors of bronchopulmonary dysplasia depending on the severity of the disease in very preterm infants

  2025cites this paper
• Third-day weight changes and bronchopulmonary dysplasia risk in preterm infants: a cohort study

  2025cites this paper
• Variations and National Perspectives on Evaluation and Management of Ventilator-Associated Pneumonia in Neonatal Intensive Care Units: An In-Depth Survey Analysis

  2024cites this paper
• Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants

  2024cites this paper
• Early Antibiotic Exposure and Bronchopulmonary Dysplasia in Very Preterm Infants at Low Risk of Early-Onset Sepsis

  2024cites this paper
• The Role of the Airway and Gut Microbiome in the Development of Chronic Lung Disease of Prematurity

  2024cites this paper
• Antibiotic Stewardship in the Neonatal Intensive Care Unit

  2024cites this paper
• Recent Advances in Bronchopulmonary Dysplasia Protection and Therapy

  2024cites this paper
• An Overview of Antibiotic Therapy for Early- and Late-Onset Neonatal Sepsis: Current Strategies and Future Prospects

  2024cites this paper
• Association between Antenatal Antibiotic Exposure and Bronchopulmonary Dysplasia: A Systematic Review and Bayesian Model-Averaged Meta-Analysis

  2024cites this paper
• 28 NICUs participating in a quality improvement collaborative targeting early-onset sepsis antibiotic use

  2024cites this paper
• [Risk factors for bronchopulmonary dysplasia in preterm infants and establishment of a prediction model].

  2024cites this paper
• Impact of antibiotic duration and type on short‐ and long‐term outcomes in very‐low‐birthweight infants

  2024cites this paper
• Improved use of antibiotics following implementation of antimicrobial stewardship in a neonatal intensive care unit

  2024cites this paper
• Risk factors for and short-term prognosis of intrauterine infection in preterm infants

  2024cites this paper
• Impact of implementation of 2019 European respiratory distress syndrome guidelines on bronchopulmonary dysplasia in very preterm infants

  2024cites this paper
• The potential role of heparin-binding protein in neonatal sepsis: research progress

  2024cites this paper
• Predictive factors for perinatal bacterial transmission from colonized mothers to delivered very-low-birth-weight infants: a retrospective cohort study

  2024cites this paper
• Short-course empiric antibiotic therapy for possible early-onset sepsis in the NICU

  2023cites this paper
• Duration of mechanical ventilation and clinical outcomes in very low birth weight infants: A single center 10-years cohort study

  2023cites this paper
• Antibiotic Use in a Neonatal Intensive Care Unit Practicing Integrative Medicine—A Retrospective Analysis

  2023cites this paper
• Pharmacotherapy of BPD: Current status & future perspectives.

  2023cites this paper
• RISK FACTORS ASSOCIATED WITH PROLONGED MECHANICAL VENTILATION IN VERY LOW BIRTH WEIGHT INFANTS

  2023cites this paper
• Association of delivery risk phenotype with early-onset sepsis in preterm infants

  2023cites this paper
• Early antibiotic exposure in very-low birth weight infants and infection risk at 3–7 days after birth

  2023cites this paper
• Short-course antibiotic therapy for pneumonia in the neonatal intensive care unit

  2023cites this paper
• New strategies to Reduce Unnecessary Antibiotic Use in the NICU: A Quality Improvement Initiative

  2023cites this paper
• Early initiation of antibiotic therapy and short-term outcomes in preterm infants: a single-centre retrospective cohort analysis

  2023cites this paper
• Perinatal origins of bronchopulmonary dysplasia—deciphering normal and impaired lung development cell by cell

  2023cites this paper
• Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018

  2023cites this paper
• Early Antibiotic Use and Neonatal Outcomes Among Preterm Infants Without Infections.

  2023cites this paper
• Short course antibiotic therapy: When is no difference the same?

  2023cites this paper
• Late-onset sepsis in very preterm infants in Norway in 2009–2018: a population-based study

  2023cites this paper
• Impact of early antibiotic exposure on the risk of colonization with potential pathogens in very preterm infants: a retrospective cohort analysis

  2022cites this paper
• Delivery Characteristics and the Risk of Early-Onset Neonatal Sepsis.

  2022cites this paper
• The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants

  2022cites this paper
• Association Between Antibiotic Overexposure and Adverse Outcomes in Very-Low-Birth-Weight Infants Without Culture-Proven Sepsis or Necrotizing Enterocolitis: A Multicenter Prospective Study

  2022cites this paper
• The Change of Cytokines and Gut Microbiome in Preterm Infants for Bronchopulmonary Dysplasia

  2022cites this paper
• When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia

  2022cites this paper
• Managing antibiotics wisely in a neonatal intensive care unit in a low resource setting

  2022cites this paper
• Recommendations for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients: Central Line-associated Blood Stream Infections Centers for Disease Control and Prevention National Center Emerging and Zoonotic Infectious Diseases

  2022cites this paper
• Reducing Early Antibiotic Use: A Quality Improvement Initiative in a Level III Neonatal Intensive Care Unit

  2022cites this paper
• Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis.

  2022cites this paper
• Increased antibiotic exposure in early life is associated with adverse outcomes in very low birth weight infants

  2022cites this paper
• Reducing Antibiotic Use in a Level III and Two Level II Neonatal Intensive Care Units Targeting Prescribing Practices for Both Early and Late-onset Sepsis: A Quality Improvement Project

  2022cites this paper
• A Neonatologist-Driven Antimicrobial Stewardship Program in a Neonatal Tertiary Care Center in Oman

  2022cites this paper
• Early Empirical Antibiotics and Adverse Clinical Outcomes in Infants Born Very Preterm: A Population-based Cohort.

  2022cites this paper
• Risk factors and machine learning prediction models for bronchopulmonary dysplasia severity in the Chinese population

  2022cites this paper
• Can we back off using antibiotics in the NICU?

  2021cites this paper
• A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study

  2021cites this paper
• An Update on the Prevention and Management of Bronchopulmonary Dysplasia

  2021cites this paper
• T Lymphocytes, Multi-Omic Interactions and Bronchopulmonary Dysplasia

  2021cites this paper
• Gut microbiota and bronchopulmonary dysplasia

  2021cites this paper
• Hygienestandards auf einer neonatologischen Intensivstation

  2021cites this paper
• Early antibiotic exposure and adverse outcomes in very preterm infants at low risk of early-onset sepsis: the EPIPAGE-2 cohort study.

  2021cites this paper
• Abuse of Antibiotics in Perinatology: Negative Impact for Health and the Economy.

  2020cites this paper
• Fostering a Healthy Intestinal Microbiome in Preterm infants.

  2020cites this paper
• [Use (and abuse) of antibiotics in perinatal medicine].

  2020cites this paper
• Bacterial Colonization within the First Six Weeks of Life and Pulmonary Outcome in Preterm Infants <1000 g

  2020cites this paper
• Reducing Vancomycin Use in a Level IV NICU

  2020cites this paper
• Use (and abuse) of antibiotics in perinatal medicine

  2020cites this paper
• Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle

  2020cites this paper
• Mismanagement of Antibiotics in Neonatal Medicine

  2020cites this paper
• Perinatal maternal antibiotic exposure augments lung injury in offspring in experimental bronchopulmonary dysplasia.

  2020cites this paper
• Metrics of neonatal antibiotic use.

  2020cites this paper
• Perspectives on Probiotics and Bronchopulmonary Dysplasia

  2020cites this paper
• Recent Advances in Understanding the Ecology of the Lung Microbiota and Deciphering the Gut-Lung Axis.

  2020cites this paper
• Hospital-level Antibiotic Use and Complexity of Care Among Neonates.

  2019cites this paper
• Antibiotic Stewardship

  2019cites this paper
• Neonatal Resource Services Medical Necessity Clinical Guideline: Early-Onset Neonatal Sepsis

  2019cites this paper
• Gut and Lung Microbiota in Preterm Infants: Immunological Modulation and Implication in Neonatal Outcomes

  2019cites this paper
• Changes in the Composition of the Gut Microbiota and the Blood Transcriptome in Preterm Infants at Less than 29 Weeks Gestation Diagnosed with Bronchopulmonary Dysplasia

  2019cites this paper
• Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia.

  2019cites this paper
• Using NHSN's Antimicrobial Use Option to Monitor and Improve Antibiotic Stewardship in Neonates.

  2019cites this paper
• Prospective audit and feedback on antibiotic use in neonatal intensive care: a retrospective cohort study

  2019cites this paper
• Duration of Initial Empirical Antibiotic Therapy and Outcomes in Very Low Birth Weight Infants

  2019influential citation
• Antibiotic Stewardship in the Neonatal Intensive Care Unit: Lessons From Oxygen

  2019cites this paper
• Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and Proteomics

  2019cites this paper
• Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review

  2019influential citation
• Antimicrobial Stewardship in Neonates: Challenges and Opportunities

  2018cites this paper
• Variability in antimicrobial use in pediatric ventilator-associated events

  2018cites this paper
• [Research advances in rational use of antibiotics in neonates].

  2018cites this paper
• Association Between Early Antibiotic Exposure and Bronchopulmonary Dysplasia or Death

  2018cites this paper
• Prolonged use of antibiotics after birth is associated with increased morbidity in preterm infants with negative cultures

  2018cites this paper
• Neonatal Antibiotic Use: How Much Is Too Much?

  2018cites this paper
• [Prolonged initial empirical antibiotic treatment and the risk of morbidity and mortality in very low birthweight infants].

  2018cites this paper
• Neonatal Antibiotic Use: What Are We Doing and Where Shall We Go?

  2018cites this paper
• Temporal Trends and Center Variation in Early Antibiotic Use Among Premature Infants

  2018cites this paper
• The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment

  2017cites this paper
• Probiotic Supplementation in Preterm Infants Does Not Affect the Risk of Bronchopulmonary Dysplasia: A Meta-Analysis of Randomized Controlled Trials

  2017cites this paper
• How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow”

  2017cites this paper
• Neonatal Resource Services Early-Onset Neonatal Sepsis Medical Necessity Guideline

  year unknowncites this paper